Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation’s most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
HealthCast
Season 3
Episode 24
27m listen
How VA is Leveraging Genomics and Big Data to Improve Lung Cancer Outcomes
Share
Lung cancer innovation at the agency is looking at technology to improve detection and treatment.
-
Dr. Michael Kelley National Program Director for Oncology VA -
Dr. Kenute Myrie Lead for Precision Oncology, Office of Research and Development VA
Related Content
-
Building the Military Health System’s AI Ecosystem
DHA and Red Hat discuss building a secure AI ecosystem, strengthening data foundations and ensuring safe AI use in military health care.
31m watch -
Marine Warfighting Lab Turns Lessons from Ukraine into Future Strategy
The Marine Corps Warfighting Laboratory uses wargaming and simulation to analyze threats, test capabilities and prepare for future conflicts.
12m listen -
Former DOL CISO on the Importance of Building Your Network
Paul Blahusch discusses leveraging your network and the power of pivoting.
7m watch -
Inside DOE’s Genesis Mission to Power AI-Driven Science
Rick Stevens explains how DOE’s Genesis mission is integrating supercomputing, AI and quantum technologies to accelerate scientific discovery.
25m watch
